Novavax becomes Australia’s 5th approved COVID-19 vaccine
The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population of 26 million. Novavax’s COVID-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia.The country has ordered 51 million doses of the U.S.-manufactured vaccine, supplied under the brand Nuvaxovid, for its population … Read more